Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PProtalix BioTherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Protalix BioTherapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement income statement flow. Revenue $19.9M. Net result $3.78M.

Income statement revenue $19.9M (+27.1% YoY).Operating income $4.67M (+298.6% YoY).Pre-tax result $4.86M (+635.2% YoY).Net result $3.78M (+2203.0% YoY).

  • License And Service: $68K (-68.8% YoY)
  • Product: $19.83M (+28.4% YoY)
  • RESEARCH AND DEVELOPMENT EXPENSES, NET: $4.35M (-27.4% YoY)
  • SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES: $3.11M (+18.6% YoY)
  • Other income: $188K
  • Income tax expense: $1.08M (+117.9% YoY)